17th week of 2013 patent applcation highlights part 38 |
Patent application number | Title | Published |
20130101460 | INHIBITING CORROSION IN AQUEOUS FILMS - In a process for the exploration for or the production of crude oil and/or natural gas, wherein metal objects are exposed to a gas for period of time sufficient to produce an aqueous film, a method including introducing a corrosion inhibitor into a fluid in contact with the subject metal under conditions sufficient to introduce the corrosion inhibitor into the aqueous film can be used to prevent excessive corrosion. Useful as the corrosion inhibitor is 2-sulfanylpropan-1-ol, also known as 2-mercapto-ethanol, and 2-mercapto-ethanol substituted with one or two methyl groups, and combinations thereof. | 2013-04-25 |
20130101461 | Foot/Footwear Sterilization System - A foot/shoe sanitizing system includes a housing having at least one opening and a set of foot/shoe support bars coupled to the housing in proximity to the at least one opening. The foot/shoe support bars support a foot or shoe placed through the opening(s). At least one ultraviolet emitting device is supported within the housing beneath the set of foot/shoe support bars. The ultraviolet emitting devices direct ultraviolet light around and/or through the set of foot/shoe support bars towards the foot or shoe placed on the foot/shoe support bars. The ultraviolet emitting devices are controllably powered by a source of power to emit ultraviolet light. In a preferred embodiment, the ultraviolet emitting device emits light that includes short wavelength ultraviolet light, causing the formation of ozone in the area of the shoe, thereby killing pathogens that are not easily killed with ultraviolet light alone. | 2013-04-25 |
20130101462 | METHOD AND SYSTEM FOR DISINFECTING AND STERILIZING HOLLOW BODIES - A hollow body sterilizing or disinfection method using a sterilizing agent, such as periacetic acid or hydrogen peroxide, introduced into a body at ambient pressure from a vaporizer includes supplying the sterilizing agent in the vaporizer as dry sterilizing agent vapor, the dry sterilizing agent vapor comprising vapor with a sterilizing agent quantity or vapor density that is at most equal to and preferably less than saturated vapor density such that upon introduction of the sterilizing agent vapor into the hollow body and upon subsequent expansion of the sterilizing agent vapor from a pressure in the vaporizer to ambient pressure, condensate formation occurs substantially only on a surface of the hollow body. | 2013-04-25 |
20130101463 | Apparatus and Kit For Encapsulating At Least One Compound For Therapeutic and/or Diagnostic Use in Erythrocytes - A portable and highly automated apparatus and method for introducing at least one compound within erythrocytes; the apparatus comprises a reusable part provided with mechanical elements such as pumps and valves and electronic units such as a control unit; the apparatus also comprises a disposable part, which is adapted to come into contact with the sample containing the erythrocytes and is provided with a system of tubes made of deformable material, a plurality of reservoirs and one or more filters; the apparatus allows a further concentration of the erythrocytes after they have been treated; the apparatus allows to introduce the compound in the erythrocytes in a virtually totally automated manner. | 2013-04-25 |
20130101464 | EXTRACORPOREAL PHOTODYNAMIC BLOOD ILLUMINATION (IRRADIATION) FOR THE TREATMENT OF CARBON MONOXIDE POISONING - Treatment of carbon monoxide poisoning of a body by removal of a portion of the blood from the body, placing the portion in an exposure cell, exposing the portion in the cell to light of wave length and intensity that causes dissociation of carbon monoxide from hemoglobin, and returning the portion to the body. The intensity and wave length of the light is sufficient to dissociate a therapeutically-effective amount of carbon monoxide from the hemoglobin in the blood. The blood is circulated from and to the body through a concentric double lumen cannula. The wave lengths of the light are 540 and/or 570 nanometers. The cell exposes the blood to at least 9.5 Joules of dissociative light per milliliter of blood, and least 9.5 Watts of dissociative light per milliliter of blood per second. Oxygen is provided to, and the dissociated carbon monoxide is removed from the system. | 2013-04-25 |
20130101465 | DEVICE FOR TREATING BLOOD IN AN EXTRACORPOREAL CIRCULATION - A device for oxygenating blood during extracorporeal circulation includes a box-like body having a first end and a second end opposite thereto and defining therebetween a treatment chamber with an inner surface. The device further includes, in the treatment chamber, at least one exchange unit having at least one flat diaphragm that is impervious to blood and has a major axis and a minor axis. The diaphragm has a winding of hollow microporous fibers. The device further includes an inlet port and an outlet port axially aligned with one another in an alignment direction. A compartment is provided for accumulation and delivery of blood to be treated, another compartment for collecting treated blood, the compartments being located downstream of the inlet port and upstream of the outlet port, between the exchange unit and the inner surface of the treatment chamber. The diaphragm is disposed with the major axis parallel to the alignment direction. | 2013-04-25 |
20130101466 | CANTILEVERED PROBE DETECTOR WITH PIEZOELECTRIC ELEMENT - A disclosed chemical detection system for detecting a target material, such as an explosive material, can include a cantilevered probe, a probe heater coupled to the cantilevered probe, and a piezoelectric element disposed on the cantilevered probe. The piezoelectric element can be configured as a detector and/or an actuator. Detection can include, for example, detecting a movement of the cantilevered probe or a property of the cantilevered probe. The movement or a change in the property of the cantilevered probe can occur, for example, by adsorption of the target material, desorption of the target material, reaction of the target material and/or phase change of the target material. Examples of detectable movements and properties include temperature shifts, impedance shifts, and resonant frequency shifts of the cantilevered probe. The overall chemical detection system can be incorporated, for example, into a handheld explosive material detection system. | 2013-04-25 |
20130101467 | INSTALLATION APPARATUS AND STERILIZING APPARATUS AND METHOD - The application relates to apparatus capable of easily mounting an indicator to a device for verifying a sterilizing effect when a sterilizing process is performed. An installation apparatus is disclosed for positioning a sterilization verifying device in a sterilizing chamber having a sterilizing chamber door, said sterilization verifying device comprising a containing chamber for containing an indicator, the containing chamber having an opening for receiving an indicator into the chamber and connected to an introduction tube for introducing a sterilizing gas into the containing chamber, the installation apparatus comprising arrangement means configured to, in a case that the sterilizing chamber door is closed, position the opening of the containing chamber with respect to an inner wall of the sterilizing chamber door, such that the inner wall and the opening are brought into contact with each other thereby sealing the containing chamber against the inner wall. | 2013-04-25 |
20130101468 | METHOD AND APPARATUS FOR CONTROLLING THE PROPAGATION OF CYANOBACTERIA IN A BODY OF WATER - An apparatus for controlling the cyanobacteria comprising a floatation platform having anchor means to position said platform on a body of water, an ultrasonic generator secured to said platform and adapted to generate ultrasonic waves at below and top of said body of water, and supply means to cause said ultrasonic generator suspended at a predetermined depth to emit ultrasonic waves, of a predetermined frequency, at a predetermined power level, to sever the chemical link existing between an accessory pigment and the chlorophyll a, both present in the photosynthesis system of the cyanobacteria, as well as a method for preventing, controlling or inhibiting the cyanobacteria population in a body of water | 2013-04-25 |
20130101469 | System and Method for Processing Reactor Polymerization Effluent - A method of treating a polymerization reactor effluent stream comprising recovering the reactor effluent stream from the polymerization reactor, flashing the reactor effluent stream to form a flash gas stream, separating the flash gas stream into a first top stream, a first bottom stream, and a side stream, wherein the side stream substantially comprises hexane, separating the first top stream into a second top stream and a second bottom stream, wherein the second bottom stream substantially comprises isobutane, and separating the second top stream into a third top stream and a third bottom stream; wherein the third top stream substantially comprises ethylene, and wherein the third bottom stream is substantially free of olefins. | 2013-04-25 |
20130101470 | Reaction Chamber for Exothermic Material - A chamber for reacting exothermic material, comprising a multilevel structure including at least: a receptacle for storing said material, corresponding to a lower level; a median level comprising a reactive load containing at least one alkaline-earth carbonate, so as to absorb heat emitted during the oxidation reaction of said material, said alkaline-earth carbonate decomposing under the effect of the heat in an endothermic reaction; an upper level comprising a cover. According to one variant, the material stored is a carbide of plutonium and/or uranium. | 2013-04-25 |
20130101471 | EXHAUST-GAS AFTERTREATMENT SYSTEM - The present disclosure relates to an exhaust-gas aftertreatment system for an internal combustion engine, having an exhaust line and having provided therein a filter arrangement which comprises a first particle filter element and a second particle filter element, wherein the first particle filter element is equipped with an active regeneration device for restoring its filtration performance. The disclosure furthermore relates to a method for operating an exhaust-gas aftertreatment system of said type and to the use thereof. | 2013-04-25 |
20130101472 | REDUCING AGENT SUPPLY DEVICE AND EXHAUST GAS DENITRIFICATION SYSTEM USING THE SAME - This invention relates to a reducing agent supply device and an exhaust gas denitrification system using the same. The reducing agent supply device includes a reducing agent supply unit for supplying a reducing agent to a selective supply unit, a water supply unit for supplying water to the selective supply unit, the selective supply unit for selectively supplying any one of the reducing agent and water supplied from the reducing agent supply unit and the water supply unit to a spray unit, and the spray unit for spraying the reducing agent or water supplied from the selective supply unit, wherein the selective supply unit supplies water to the spray unit when the spray unit is blocked due to solidification of the reducing agent which remains behind therein because of a process in which the spray unit continuously sprays the reducing agent or a temporary malfunction of the device, thereby preventing blockage of the spray unit. Also an exhaust gas denitrification system using the device is provided. | 2013-04-25 |
20130101473 | METHOD FOR REMOVAL OF HYDROGEN SULFIDE FROM GEOTHERMAL STEAM AND CONDENSATE - A method for scavenging hydrogen sulfide from geothermal steam in a condenser under vacuum. A fine curtain of atomized acrolein-water droplets may be sprayed into geothermal steam condensers in an amount of approximately 2:1 molar ratio of acrolein to H | 2013-04-25 |
20130101474 | EXHAUST PURIFICATION DEVICE OF INTERNAL COMBUSTION ENGINE - An ambient NO | 2013-04-25 |
20130101475 | PROCESS AND APPARATUS FOR PRODUCING DIESEL - A process and apparatus are disclosed for hydrocracking hydrocarbon feed in a hydrocracking unit and hydrotreating a diesel product from the hydrocracking unit in a hydrotreating unit. The hydrocracking unit and the hydrotreating unit share the same recycle gas compressor. A make-up hydrogen stream may also be compressed in the recycle gas compressor. A warm separator separates recycle gas and hydrocarbons from diesel in the hydrotreating effluent, so fraction of the diesel is relatively simple. The warm separator also keeps the diesel product separate from the more sulfurous diesel in the hydrocracking effluent, and still retains heat needed for fractionation of lighter components from the low sulfur diesel product. | 2013-04-25 |
20130101476 | TWO STAGE DRY FEED GASIFICATION SYSTEM - A dry feed two stage gasification system and process is disclosed for gasifying feedstock such as carbonaceous materials with improved energy efficiency, along with reductions in feedstock consumption and carbon dioxide emissions. The feedstock is first dried and pretreated with the hot syngas in the upper section of the gasifier to generate a dry char that is low in volatile-matter content. This dry char is sent to the first stage of a two stage gasifier where it reacts with oxygen in the presence of steam to produce a hot syngas stream. | 2013-04-25 |
20130101477 | NON-WOVEN ELECTRET FIBROUS WEBS AND METHODS OF MAKING SAME - Non-woven electret fibrous webs including electret fibers, multicomponent fibers, and sorbent particles, and pleated filters made therefrom. | 2013-04-25 |
20130101478 | Stackable cartridges for bulk feeders - A set of vertically stackable interacting cartridges for improving the delivery of biocide of a bulk feeder by positioning the stackable cartridges in a stacked condition within a chamber in the bulk feeder wherein the stackable cartridges are maintained in vertical interacting flow alignment with each other to provide enhanced control of the delivery of the biocide carried within each of the stackable cartridges without replacing the control valves of the bulk feeder. | 2013-04-25 |
20130101479 | PETRI DISH PROVIDED WITH MEANS FORMING EVIDENCE OF USE - A Petri dish includes a receptacle and a matching lid, which both have a shape of revolution and are each delimited by a bottom wall and at least one peripheral rim. This also includes fingers and complementary locking elements. The receptacle and the lid, when rotated relative to each other, are able to occupy three or four different positions, including at least a “first position” and an “intermediate position”. This dish is distinguished by the fact that the locking elements carry at least one blocking member which blocks the fingers in the “intermediate position” and which opposes the return to the “first position”. | 2013-04-25 |
20130101480 | BIO CHIP - There is provided a bio-chip. The bio-chip includes: a first substrate including a plurality of micro-wells formed in one surface thereof to a predetermined depth, the bottom face of each micro-well being hydrophilic and a lateral side thereof being hydrophobic; and a second substrate combined with the first substrate and including amounts of biomaterials inserted into the micro-wells, the amounts of biomaterials being provided at predetermined intervals. | 2013-04-25 |
20130101481 | MICROTITER PLATES AND METHODS OF USE - Described herein are polymer low profile microtiter plates suitable for use in a variety of laboratory and clinical settings. The microtiter plates described herein also are compatible with automated or manual liquid dispensing devices and high throughput robotic biological work stations. | 2013-04-25 |
20130101482 | SYSTEMS AND DEVICES FOR RESTRAINING A MICRO-OBJECT AND ASSOCIATED METHODS - Systems, devices, and methods for restraining a micro-object are provided. In one aspect, a micro-object restraint device is provided having a micro-barrier structure coupled to a support substrate, where the micro-barrier structure has two micro-object holding regions. Each micro-object holding region includes a micro-object receiving opening defined in the micro-barrier structure, a micro-object impeding opening at an internal region of the micro-barrier structure, and at least two contact points positioned adjacent to the micro-object impeding opening and oriented to contact and impede a micro-object at the micro-object opening. The two micro-object holding regions abut one another and the micro-object openings from the two micro-object holding regions are continuous. | 2013-04-25 |
20130101483 | PROCESS FOR EXTRACTING METALS FROM ALUMINOFERROUS TITANOFERROUS ORES AND RESIDUES - A process for extracting metal values from ores or residues is disclosed. The process mentioned above is mainly suitable for aluminoferrous ores such as bauxite, titanoferrous ores such as ilmenite, or residues such as red mud waste. The process involves pulverizing the ore and/or residue and mixing with a carbonaceous material, followed by smelting the iron values and slag in the mixture to yield molten iron and oxides of aluminum and titanium. The process is simple, cost-effective, and provides effective extraction of high purity metal values. | 2013-04-25 |
20130101484 | METHOD FOR THE PRODUCTION OF BATTERY GRADE LITHIUM CARBONATE FROM NATURAL AND INDUSTRIAL BRINES - It is possible to produce battery grade metallic lithium from naturally occurring or industrial brine by a process comprising the following steps: (i) precipitating magnesium with calcium hydroxide; (ii) removal of boron via extraction of solvents; (iii) precipitation of lithium with sodium carbonate; (iv) transformation of lithium carbonate to bicarbonate of lithium with carbonic acid; (v) decomposition of bicarbonate of lithium into high purity lithium carbonate as a result of heating of the solution. Re-precipitation of lithium carbonate by the formation of bicarbonate of lithium allows for the removal of the majority of contaminants which co-purify with lithium carbonate and yield battery grade highly purified lithium carbonate. | 2013-04-25 |
20130101485 | METHOD FOR CONTROLLING AN INJECTION DEVICE FOR FEEDING AN AMMONIA-RELEASING REDUCING AGENT INTO AN EXHAUST-GAS PURIFICATION SYSTEM OF AN INTERNAL COMBUSTION ENGINE - The present disclosure relates to a method for controlling an injection device for feeding an ammonia-releasing reducing agent into an exhaust-gas purification system of an internal combustion engine for the purpose of reducing the nitrogen oxide emissions, wherein the exhaust-gas purification system comprises at least one SCR catalytic converter with n cells which are arranged in series in the exhaust-gas throughflow direction and in which ammonia can be stored. | 2013-04-25 |
20130101486 | ON-LINE MONITORING AND CONTROLLING OF SULFUR COMPOUNDS IN POWER GENERATION FACILITIES FOR CARBON DIOXIDE CAPTURE PROCESSES AND ARTICLES COMPRISING THE SAME - An online monitoring and controlling system is used for monitoring and controlling sulfur content in heat stable salts or in a flue gas stream. The system comprises valves, sensors and analyzers that are operated by a valve flow and control system that regulates the valves to redirect flow of the heat stable salt or the flue gas stream to reduce the sulfur to below a desirable value. The valve and flow control system is automated and uses a feedback loop to control the sulfur content. | 2013-04-25 |
20130101487 | GAS ANALYSIS DEVICE, MERCURY REMOVAL SYSTEM, GAS ANALYSIS METHOD, AND REMOVAL METHOD FOR MERCURY IN FLUE GAS - A gas analysis device according to the present invention includes a flue-gas extraction pipe for extracting flue gas from a flue gas duct to which flue gas including both of NH | 2013-04-25 |
20130101488 | OPTIMIZED BORON POWDER FOR NEUTRON DETECTION APPLICATIONS - An optimized boron powder is provided. The quantity of a soluble residue comingled with the optimized boron powder is less than 7.00×10 | 2013-04-25 |
20130101489 | FOULING REDUCTION IN HYDROCHLOROSILANE PRODUCTION - Embodiments of a method for reducing iron silicide and/or iron phosphide fouling and/or corrosion in a hydrochlorosilane production plant are disclosed. Sufficient trichlorosilane is included in a silicon tetrachloride process stream to minimize hydrogen chloride formation, thereby inhibiting iron (II) chloride formation and reducing iron silicide and/or iron phosphide fouling, superheater corrosion, or a combination thereof. | 2013-04-25 |
20130101490 | Process for Producing Ammonia Synthesis Gas - A process for producing ammonia synthesis gas from a hydrocarbon-containing feedstock, with steps of primary reforming, secondary reforming with an oxidant stream, and further treatment of the synthesis gas including shift, removal of carbon dioxide and methanation, wherein the synthesis gas delivered by secondary reforming is subject to a medium-temperature shift (MTS) at a temperature between 200 and 350° C., and primary reforming is operated with a steam-to-carbon ratio lower than 2. A corresponding method for revamping an ammonia plant is disclosed, where an existing HTS reactor is modified to operate at medium temperature, or replaced with a new MTS reactor, and the steam-to-carbon ratio in the primary reformer is lowered to a value in the range 1-5-2, thus reducing inert steam in the flow rate trough the equipments of the front-end. | 2013-04-25 |
20130101491 | METHOD OF FORMING PHASE CHANGE MATERIAL LAYER USING GE(II) SOURCE, AND METHOD OF FABRICATING PHASE CHANGE MEMORY DEVICE - In one aspect, a method of forming a phase change material layer is provided. The method includes supplying a reaction gas including the composition of Formula 1 into a reaction chamber, supplying a first source which includes Ge(II) into the reaction chamber, and supplying a second source into the reaction chamber. Formula 1 is NR | 2013-04-25 |
20130101492 | GEOTHERMAL ENERGIZATION OF A NON-COMBUSTION CHEMICAL REACTOR AND ASSOCIATED SYSTEMS AND METHODS - Systems and methods for heating a non-combustion chemical reactor with thermal energy from a geothermal heat source are described. A working fluid is directed from the geothermal heat source to the chemical reactor to transfer heat. The working fluid can be circulated in a closed system so that it does not contact material at the geothermal heat source, or in an open system that allows the working fluid to intermix with material at the geothermal heat source. When intermixing with material at the geothermal heat source, the working fluid can transport donor substances at the geothermal heat source to the chemical reactor. | 2013-04-25 |
20130101493 | AQUEOUS SOLUTION CAPABLE OF ABSORBING AND COLLECTING CARBON DIOXIDE IN EXHAUST GAS WITH HIGH EFFICIENCY - Disclosed is an aqueous solution for absorbing and recovering carbon dioxide from a carbon dioxide-containing gas, the aqueous solution containing 50 to 70 wt % of a secondary amine compound represented by Formula (1): | 2013-04-25 |
20130101494 | Hydrophilic Silicone Copolymers Useful In Carbon Fiber Production - Robust oiling agent compositions for use in preparing carbon fibers from acrylic polymer carbon fiber precursors contain at least one silicone copolymer minimally containing an organopolysiloxane moiety, a polyoxyalkylene polyether moiety, and at least one internal or terminal urea or urethane group. | 2013-04-25 |
20130101495 | SYSTEMS AND METHODS FOR CONTINUOUSLY PRODUCING CARBON NANOSTRUCTURES ON REUSABLE SUBSTRATES - A system includes a reusable substrate upon which a carbon nanostructure is formed as a carbon nanostructure-laden reusable substrate, a first conveyor system adapted to continuously convey the reusuable substrate through a carbon nanotube catalyst application station and carbon nanostructure growth station, and a second conveyor system adapted to create an interface between a second substrate and the carbon nanostructure-laden reusuable substrate, the interface facilitating transfer of a carbon nanostructure from the carbon nanostructure-laden reusuable substrate to the second substrate. A method includes growing a carbon nanostructure on a reusable substrate, the carbon nanostructure includes a carbon nanotube polymer having a structural morphology comprising interdigitation, branching, crosslinking, and shared walls and transferring the carbon nanostructure to a second substrate to provide a carbon nanostructure-laden second substrate. The method is adapted for continuous carbon nanostructure production on the reusable substrate. A pre-preg includes such a carbon nanostructure. | 2013-04-25 |
20130101496 | GRAPHITE THERMAL DECONTAMINATION WITH REDUCING GASES - Providing a roaster that operates at temperatures in the range of 800° Celsius to 2000° Celsius with inert, optional oxidizing and reducing gases to treat graphite contaminated with radionuclides including tritium, carbon-14, and chlorine-36. The combination of temperatures and gases allow for the removal of most to substantially all the carbon-14 within the graphite while substantially limiting gasifying the bulk graphite. | 2013-04-25 |
20130101497 | PROCESS FOR THE FORMATION OF FOLIATED FINE GRAPHITE PARTICLES - A low-temperature process for preparing flat carbon based nanostructured material, and namely foliated, fine graphite particles having low thickness and high aspect ratio. The process comprises the steps of: subjecting a particulate graphite to a mechanical attrition treatment in the presence of an alkaline reactant or a mixture comprising the alkaline reactant; exposing the graphite particles to an intercalating solvent to cause the solvent to penetrate between carbon layers of graphite; and delivering an ultrasonic energy into a dispersion of the graphite particles for a period of time sufficient to cause the formation of the nanostructured material. The carbon based nanostructures (CBNS) obtained by this method have a thickness in the range of 4-20 nm and an aspect ratio 500-7000 and various surface chemistry, and can be used as a highly functional graphite material in a wide range of applications, in particular for electrochemical applications in batteries and fuel cells. | 2013-04-25 |
20130101498 | Filmy Graphite and Process for Producing the Same - A process for producing a filmy graphite includes the steps of forming a polyimide film having a birefringence of 0.12 or more and heat-treating the polyimide film at 2,400° C. or higher. | 2013-04-25 |
20130101499 | METHODS FOR ELECTROCHEMICAL DECHLORINATION OF ANOLYTE BRINE FROM NaCl ELECTROLYSIS - Methods for the reductive post-treatment of NaCl-containing solutions, wherein such methods comprise: providing a NaCl-containing solution obtained from an anode side of an NaCl electrolysis cell, the solution comprising reducible components; and subjecting the solution to cathodic electrochemical reduction. | 2013-04-25 |
20130101500 | DROPLET GENERATION SYSTEM AND METHOD - A droplet generation system includes a first nozzle configuration structured to receive a liquid and a gas under pressure in a controllable feed ratio, and to merge the liquid and gas to form an intermediate stream that is a mixture of the gas and of a dispersed phase of the liquid. A second nozzle configuration is connected to receive the intermediate stream from the first nozzle configuration and has a valve mechanism with one or more controllable operating parameters to emit a stream of droplets of the liquid. The mean size of the droplets is dependent on the controllable feed ratio of the liquid and gas and the flow rate of the stream of droplets is dependent on the controllable operating parameter(s) of the valve mechanism. A corresponding method is disclosed, as is the application of the system and method to the production of nanoparticles in a thermochemical reactor. | 2013-04-25 |
20130101501 | URCHIN-LIKE IRON OXIDE AND A METHOD FOR PRODUCING THE URCHIN-LIKE IRON OXIDE - The present invention relates to an urchin-like iron oxide and a method for producing the urchin-like iron oxide. The urchin-like iron oxide comprises a core and multiple needle-like elongations protruded from the core. The needle-like elongations could be wire, rod, tube, cone, and flake. The length/width ratio of the needle-like elongation is high enough to apply in an optoelectronic field. The method in accordance with the present invention is to stably heat an iron-contained powder under room temperature by a thermal oxidation. The surface of the iron-contained powder is slow oxidized to form an urchin-like iron oxide with multiple uniform distributed needle-like elongations protruded from the surface. The size of each needle-like elongation is easily adjusted and changed by controlling the heating temperature. The method has advantages of simplified operation and lowered expense. | 2013-04-25 |
20130101502 | REDUCING AND/OR HARVESTING DRAG ENERGY FROM TRANSPORT VEHICLES, INCLUDING FOR CHEMICAL REACTORS, AND ASSOCIATED SYSTEMS AND METHODS - The present disclosure is directed to systems and methods for reducing and/or harvesting drag energy from transport vehicles. A system in accordance with a particular embodiment includes a mobile transport platform, a donor substance source carried by the platform, and a thermochemical reactor carried by the platform and coupled to the donor substance. The reactor is configured to carry out a non-combustion dissociation process that dissociates the donor substance into a first constituent and a second constituent. An energy extraction system carried by the transport platform and positioned to extract energy from an airstream passing the transport platform is coupled to the reactor to provide energy for the dissociation process. | 2013-04-25 |
20130101503 | Process For The Production Of A Core/Shell Zeolitic Material Having A CHA Framework Structure - The present invention relates to a process for the preparation of a zeolitic material having a CHA framework structure, said zeolitic material comprising zeolite crystals having a core-shell structure, wherein said process comprises the steps of
| 2013-04-25 |
20130101504 | SPARC BINDING ANTIBODIES AND USES THEREOF - The invention provides SPARC binding antibodies that target disease sites, in particular, tumors and uses thereof to diagnose and treat diseases, in particular, cancerous tumors. | 2013-04-25 |
20130101505 | Stable Activatable Particles as Radiotherapeutic Agents for the Treatment of Disease - The present invention provides radiotherapeutic agents and compositions and methods for making and using the same. In some embodiments, the radiotherapeutic agent is a nanoparticle comprising a radionuclide and a carrier moiety. In some embodiments, the radionuclide is produced by activating a stable activatable particle via neutron activation. | 2013-04-25 |
20130101506 | COMPOSITIONS COMPRISING NUCLEIC ACID APTAMERS - Disclosed herein are aptamers that comprise a nucleic acid sequence that has a specific affinity for a target. These aptamers can be used as delivery vehicles to deliver specific agents to particular sites. Alternatively, targeted aptamers can also be used with detection techniques to determine the presence of absence of specific targets in heterogeneous backgrounds. | 2013-04-25 |
20130101507 | Treatment of Renal Cell Carcinoma - Methods for treating renal cancer by administration of certain 3,3′,4,4′-tetrahydroxy-2,2′-bipyridine-N,N′-dioxide compounds, especially 3,3′,4,4′-tetrahydroxy-2,2′-bipyridine-N,N′-dioxide (Orellanine), conjugated to an alpha-emitting radionuclide (e.g. Astatine-211) to increase the efficacy of the formulation and/or a large molecule (e.g. a oligomer/polymer such as a PEG or a polysaccharide such as a dextran or a Ficoll®) to reduce the filtration and consequently the renal exposure. Particular administration protocols and dosing regimens, as well as pharmaceutical compositions suitable for use in the treatment methods can be used. | 2013-04-25 |
20130101508 | STABILIZATION OF RADIOPHARMACEUTICAL COMPOSITIONS USING ASCORBIC ACID - Radiopharmaceutical compositions, and related methods, useful for medical imaging are provided. The radiopharmaceutical compositions include one or more radiopharmaceutical compounds, together with a stabilizer comprising ascorbic acid, wherein the pH of said composition is within the range of about 3.5-5.5. | 2013-04-25 |
20130101509 | IMAGING AND RADIOTHERAPY METHODS - The present invention relates to in vivo imaging and radiotherapeutic methods and agents which target the enzyme aldehyde dehydrogenase (ALDH) and that are suitable for the in vivo imaging of tumours and treatment of cancer. | 2013-04-25 |
20130101510 | METHODS OF TREATING PARKINSON'S DISEASE USING VIRAL VECTORS - Methods of delivering viral vectors, particularly recombinant AAV virions, to the CNS are provided. Also provided are methods of treating Parkinson's Disease. | 2013-04-25 |
20130101511 | IN VIVO IMAGING OF ENZYMATIC ACTIVITY - Compositions and methods are described for detecting enzyme activity in a live organism (e.g., animal) are provided. | 2013-04-25 |
20130101512 | CROSSLINKED POLYNUCLEOTIDE STRUCTURE - The present invention provides structures formed from crosslinked polynucleotides, where a subset of the polynucleotides binds to a target under physiological conditions, where the signal group detectably changes upon binding. | 2013-04-25 |
20130101513 | METHOD OF USING NEAR INFRARED FLUORESCENT DYES FOR IMAGING AND TARGETING CANCERS - The present invention describes methods of identifying, detecting, imaging, isolating and locating cancer cells in a subject. The method invokes the use of near-infrared (NIR) organic carbocyanine dyes, particularly, near infrared heptamethine cyanine dyes and the detection of the fluorescence of these NIR dyes. The uptake of these dyes by cancer cells and not by normal cells, as well as their high intensity, among other things, allow for the detection of cancerous cells in a subject and facilitate their subsequent isolation. Further, detection of many tumor types and tumor cell populations under cell culture and in vivo conditions are described. | 2013-04-25 |
20130101514 | COMPOSITIONS AND METHODS FOR TREATING NEPHROPATHY - Activated fatty acids, pharmaceutical composition compositions including activated fatty acids, methods for using activated fatty acids to treat nephropathy, and methods for preparing activated fatty acids are provided herein. | 2013-04-25 |
20130101515 | METHOD OF SELECTING ANTIOXIDANTS FOR USE IN TOPICALLY APPLIED COMPOSITIONS - The invention provides antioxidant-containing compositions and methods for confirming antioxidant activity of a composition formulated for topical application to skin. The invention also provides methods for testing a composition for the ability to inhibit both ultraviolet radiation-induced lipid peroxidation on skin and ultraviolet radiation-induced reactive oxygen species formation in the stratum corneum, as well as compositions and methods for treating and preventing photodamage to skin. | 2013-04-25 |
20130101516 | NANOPARTICLES AND NANOPARTICLE COMPOSITIONS - The invention provides multivalent surface-crosslinked micelle (SCM) particles, crosslinked reverse micelle (CRM) particles, and methods of making and using them. The SCM particles can be used, for example, to inhibit a virus or bacteria from binding to a host cell. The inhibition can be used in therapy for the flu, cancer, or AIDS. The CRM particles can be used, for example, to prepare metal nanoparticles or metal alloy nanoparticles, or they can be used in catalytic reactions. | 2013-04-25 |
20130101517 | DEVELOPMENT OF PHOTOSTABLE NEAR-IR CYANINE DYES FOR IN VIVO IMAGING - A compound of structural formula (I): | 2013-04-25 |
20130101518 | METHOD AND APPARATUS FOR KIDNEY FUNCTION ANALYSIS - A method and apparatus for determining physiological data related to an animal, such as kidney diagnostics data, is provided. The method includes injecting a mixture of a first and a second molecule into an animal (e.g., a human patient), determining a molecular ratio of the molecules, and determining the physiological data based on the molecular ratio. The apparatus includes a number of finger receiving apertures, a light generation circuit, a light detection circuit, a pulse counting circuit, and a user interface. | 2013-04-25 |
20130101519 | Diagnostic Method for Atherosclerosis - The invention relates to a method of identifying/monitoring active atherosclerotic plaques associated with blood vessel walls wherein the plaques comprise activated macrophages having accessible binding sites for a ligand. The method comprises the steps of administering to a patient being evaluated for atherosclerosis an effective amount of a composition comprising a conjugate of a ligand and a chromophore capable of emitting light under predetermined conditions, allowing sufficient time for the ligand conjugate to bind to the activated macrophages, subjecting the blood vessels to the predetermined conditions using a catheter-based device, and identifying active plaques by detecting light emitted by the chromophore using a catheter-based device or by using an external imaging technique. The invention also relates to a similar method wherein a chemical moiety capable of emitting radiation is conjugated to the ligand. | 2013-04-25 |
20130101520 | ULTRASOUND CONTRAST AGENTS AND METHODS OF MAKING AND USING THEM - The invention is directed to injectable suspensions of gas-filled microvesicles, as well as methods of preparing and using the same, especially as ultrasound contrast agents. | 2013-04-25 |
20130101521 | METHODS DEVICES AND SYSTEMS OF PREPARING TARGETED MICROBUBBLE SHELLS - Targeted microbubbles are generated by post-labeling buried ligand microbubbles. According to embodiments, buried ligand microbubbles are created with steric brushes protecting functionalized polymer tethers. Ligands were attached to the functionalized tethers by diffusion of ligands of a small size through the steric barrier. The steric barrier was substantially capable of hindering access to the tethers by larger molecules. The embodiments disclosed include methods for creating microbubble batches that can be loaded with selected ligands, for titrating the targeting ligands thereby to reduce waste and cost, and for using resulting buried ligand molecules for medical purposes. | 2013-04-25 |
20130101522 | Ultrasound Contrast Agents And Process For The Preparation Thereof - Injectable aqueous suspension of microbubbles filled with a biocompatible gas and a method of preparation thereof. At least 10% of the total volume of gas contained in the microbubbles is contained in microbubbles with a diameter of 1.5 μm or less. The microbubbles can be obtained by preparing an emulsion comprising an aqueous medium, a phospholipid and a water immiscible organic solvent. The emulsion is then freeze-dried and then reconstituted in an aqueous suspension of gas-filled microbubbles. | 2013-04-25 |
20130101523 | METHODS FOR DETECTING A MYCOBACTERIUM TUBERCULOSIS INFECTION - Methods for detecting an infection with | 2013-04-25 |
20130101524 | SEMULOPARIN FOR THE EXTENDED PREVENTION OF A MORTALITY AND/OR MORBIDITY EVENT IN A PATIENT HAVING UNDERGONE HIP FRACTURE SURGERY - The invention relates to the use of semuloparin or a pharmaceutically acceptable salt thereof for the extended prevention of a mortality and/or morbidity event, more specifically venous thromboembolism and death, in a patient having undergone hip fracture surgery. | 2013-04-25 |
20130101525 | VITAMIN FORMULATION - A pharmaceutical aerosol foam composition, comprising: an effective amount of a pharmaceutically active ingredient, wherein said pharmaceutically active ingredient is a vitamin or analogue thereof; an occlusive agent; an aqueous solvent; an organic cosolvent; wherein the pharmaceutically active ingredient is insoluble in both water and the occlusive agent; and the occlusive agent being present in an amount sufficient to form an occlusive layer on the skin, in use. In a second embodiment, an oil-in water emulsion having a vitamin, an occlusive agent; an aqueous solvent; and an organic cosolvent, wherein the occlusive agent is present in an amount sufficient to form an occlusive layer on the skin. | 2013-04-25 |
20130101526 | Treatment Methods Using Disinfecting Compositions Containing a Polymer Complex of Organic Acid - The present invention provides compositions which not only effectively kill a broad spectrum of microorganisms present on surfaces on contact but continue to kill microorganisms for a period of time thereafter. | 2013-04-25 |
20130101527 | METHODS, COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS FOR TREATING NEUROLOGICAL DISORDERS - Pharmaceutical compositions or formulations containing octanol are provided. The pharmaceutical compositions are useful for the prevention and treatment of a variety of conditions in mammals including humans, including neurological disorders such as thalamocortical dysrhythmia disorder. | 2013-04-25 |
20130101528 | DENTIFRICE FORMULATION SUITABLE FOR PREGNANT OR NURSING WOMEN - The invention relates to a dentifrice formulation which is particularly well suited for pregnant women, nursing women, or women trying to fall pregnant. The dentifrice formulation includes, as active ingredients: a source of fluoride ions, an abrasive agent, xylitol, and an anti-gingivitis agent; and as other ingredients: a surfactant, a humectant, a thickening agent, and an anti-inflammatory agent, thereby comprising therapeutic agents at least to control the incidence and severity of pregnancy gingivitis and tooth decay. | 2013-04-25 |
20130101529 | Composition for treating and/or preventing periodontal disease - A method for preventing periodontal disease, which comprises administering an effective amount of a composition to a method for preventing periodontal disease comprising administering an effective amount of a composition to a part in an oral cavity before a periodontal disease-related bacteria, a decayed teeth-related bacteria, and/or | 2013-04-25 |
20130101530 | ANTIMICROBIAL PRESERVATIVE COMPOSITIONS FOR PERSONAL CARE PRODUCTS - A personal product antimicrobial preservative composition for preservation of topical personal care formulations is provided comprising [A] one or more undecylenic acid derivatives depicted by Formula (I), | 2013-04-25 |
20130101531 | ETHANOL-FREE AQUEOUS PERFUME COMPOSITION - The present invention relates to an ethanol-free, non-fatty, non-sticky perfumed aqueous cosmetic microemulsion composition, including one or more fragrance materials, a solvent, an aqueous medium, and optionally, one or more surfactants; wherein the solvent in the microemulsion is a vicinal diol such as 1,2-hexanediol. | 2013-04-25 |
20130101532 | SYNERGISTIC UVR ABSORBING ADJUVANT COMBINATION - A composition comprising ethylhexyl methoxycrylene, a compound with multiple phenyl groups, and a carrier oil is provided. The composition may also include an organic sunscreen. The combination exhibits an unexpected synergistic effect, in that the photoactive properties of the composition (e.g., SPF, UV absorption) are significantly higher than would be predicted based on the values for each of the components individually. | 2013-04-25 |
20130101533 | PHARMACEUTICAL COMPOSITIONS COMPRISING DGLA AND/OR 15-HETRE AND METHODS OF USE THEREOF - The present disclosure provides compositions comprising fatty acids, or derivatives thereof (e.g., C1-C4 esters) including, for example, DGLA, and/or 15-HETrE, used singly or in combination for the prevention and/or treatment of effects associated with UV radiation such as erythema. | 2013-04-25 |
20130101534 | SKIN TREATMENTS CONTAINING CARBOXYLIC ACID-SUBSTITUTED IDEBENONE DERlVATIVES AND METHODS OF PREPARATION AND USE THEREOF - The present invention relates to novel carboxylic acid-substituted idebenone derivatives, skin treatment compositions containing these carboxylic acid-substituted derivatives, methods of treating skin changes by topical application of these carboxylic acid-substituted idebenone derivatives, and their methods of synthesis. The carboxylic acid-substituted idebenone derivatives of the present invention are unexpectedly effective in treating skin, particularly with respect to skin tolerance. When included in a topical composition, the carboxylic acid-substituted idebenone derivatives of the present invention have an antioxidant effect that is useful in treating a skin change. | 2013-04-25 |
20130101535 | ALDEHYDE DEHYDROGENASE INHIBITORS AS NOVEL DEPIGMENTING AGENTS - The present invention provides methods and compositions for reducing pigmentation. | 2013-04-25 |
20130101536 | Odor Reduction Compositions - An odor-reducing composition for counteracting malodour in which the composition includes an odor reducing material of the type phenyl ethyl methyl ether, Cyprisate, Camonal and paracresyl methyl ether and a method for counteracting malodour employing such a composition. | 2013-04-25 |
20130101537 | SKIN-WHITENING COMPOSITION CONTAINING EXTRACTS FROM TREES INCLUDING PAPER MULBERRY - The present invention relates to a skin-whitening composition comprising a paper mulberry extract, and more particularly to a skin-whitening composition containing an extract of | 2013-04-25 |
20130101538 | LIQUID COSMETIC - Provided is a liquid cosmetic which can suitably be used for a liquid cosmetic applicator using a brush or a pen feed as an applying means and which has good water resistance and is excellent in an adhesive property to the skin. The liquid cosmetic comprises at least carbon black, water, 0.5 to 5% by mass of a dispersant comprising a film-formable resin, 2 to 15% by mass (in terms of a solid content) of a film-forming agent and 0.5% by mass or less of a surfactant, and a viscosity thereof measured at a temperature of 25° C. and a shear rate of 3.83 S | 2013-04-25 |
20130101539 | Lip Cosmetics - The present invention provides a lip cosmetic that has excellent secondary adhesion resistance effect, good gloss, and excellent stability. The lip cosmetic of the present invention is characterized by comprising the following components (a) to (c):
| 2013-04-25 |
20130101540 | AQUEOUS DISPERSIONS OF POLYURETHANE AND NANOPARTICLES - The present disclosure is directed to aqueous dispersions comprising polyurethane and nanoparticles, and processes for preparing the aqueous dispersions. The dispersions comprise aqueous polyurethane dispersions having nanoparticles covalently incorporated into the polymer matrix. The dispersions are prepared by reacting isocyanate groups present on the polyurethane chain ends with free amine groups on a hydroxy- or amino-functionalized nanoparticle to covalently attach the polyurethane and the nanoparticle through urethane or urea linkages, respectively. | 2013-04-25 |
20130101541 | Conditioning Agents For Personal Care Compositions - An emollient represented by the formula: | 2013-04-25 |
20130101542 | COMPOSITIONS CONTAINING ACRYLIC THICKENER - The invention relates to a composition, especially a cosmetic composition, comprising at least one acrylic thickener having a high viscosity and a low solids content, as well as to methods of using such compositions. | 2013-04-25 |
20130101543 | Blends Of Acrylic Copolymer Thickeners - Disclosed are blends of acrylic polymers comprising at least one crosslinked acrylic copolymer and at least one linear acrylic copolymer. The acrylic polymer blends surprisingly provide desirable rheological, clarity, and aesthetic properties in aqueous surfactant containing compositions, particularly at low pH. | 2013-04-25 |
20130101544 | LOW VOLATILE REACTIVE MALODOR COUNTERACTIVES AND METHODS OF USE THEREOF - The present invention provides a novel compound for counteracting amine-based malodor in consumer, industrial and textile products. | 2013-04-25 |
20130101545 | Low Volatile Reactive Malodor Counteractives and Methods of Use Thereof - The present invention provides a novel compound for counteracting amine-based malodor in consumer, industrial and textile products. | 2013-04-25 |
20130101546 | Protein-Polymer-Drug Conjugates - A drug conjugate is provided herein. The conjugate comprises a protein based recognition-molecule (PBRM) and a polymeric carrier substituted with one or more -L | 2013-04-25 |
20130101547 | THERMORESPONSIVE COMPOSITIONS FOR DERMATOLOGICAL USE AND METHODS THEREOF - The present specification generally relates to compositions comprising a thermoresponsive polymer and methods of treating a soft tissue condition using such compositions. | 2013-04-25 |
20130101548 | Whey Protein Isolate Hydrogels and Their Uses - A biodegradable hydrogel has been made based on high concentrations of whey protein isolate (WP1). WP1 gels of different compositions were fabricated by thermally inducing gelation of high-concentration suspensions of protein, and characterized for compressive strength and modulus, hydration swelling and drying properties, mechanical behavior change due to polysaccharide additives, and intrinsic pore network structure. The gels were shown to be compatible with bone cells and could be used as bone tissue scaffolds. In addition, WP1 fibers were produced by electrospinning. Several additives could be incorporated into the WPI gels, including structural additives, growth factors, amino acids, etc. The WP1 hydrogels can be made with glycerol to increase flexibility and stability. The hydrogels could be used for tissue regeneration, food protection, controlled-release applications (including drug encapsulation, dietary supplement release, attractant release in lures, nutrient release to plants (fertilizers), column packing for compound separation, and membrane development. | 2013-04-25 |
20130101549 | LIGHT TARGETING MOLECULES AND USES THEREOF - LIGHT-targeting molecules (e.g., LIGHT fusion molecules), compositions, e.g., pharmaceutical compositions thereof, are disclosed. Methods of using these molecules to treat, prevent and/or diagnose hyperproliferative, e.g., neoplastic, diseases or conditions, including, but not limited to, cancer and metastasis are also provided. | 2013-04-25 |
20130101550 | PRODUCT AND METHOD FOR PERMEABILISATION OF TUMOR VASCULATURE - The present invention provides a tumour vasculature permeabilising molecule for use in permeabilising vasculature of a tumour for treating, detecting or diagnosing said tumour wherein said tumour vasculature permeabilising molecule is formulated for systemic administration to said patient. A composition comprising a tumour vasculature permeabilising molecule and an appropriate anticancer agent or imaging agent, and a method of treatment or a method of detecting the presence or absence of a tumour are also provided. | 2013-04-25 |
20130101551 | Induction of IL-12 using immunotherapy - The present invention relates to compositions and methods that promote the induction of IL-12 in a patient. The composition includes activated allogeneic cells that are administered to a patient with a disease such as cancer. Administration of the composition skews the patient's immune response to a Th1 environment and produces detectable levels of IL-12 in the patient's plasma, without any IL-12 related toxicity. | 2013-04-25 |
20130101552 | METHODS AND COMPOSITIONS FOR CONTRIBUTING TO THE TREATMENT OF CANCERS - Methods and compositions for contributing to the treatment of cancers, especially ovarian tumors, are disclosed. The methods and compositions utilize an endothelin B agonist (ET | 2013-04-25 |
20130101553 | INDUCING INACTIVATION OF FIBROGENIC MYOFIBROBLASTS - Provided are methods of treating fibrotic conditions in a subject and diagnostic methods for determining fibrosis and appropriate treatments for the fibrosis by the identification of specific subsets of fibrogenic myofibroblasts. | 2013-04-25 |
20130101554 | THERAPEUTIC REGIMEN COMPRISING PEG-INTERFERON, RIBAVIRIN AND VX-950 FOR THE TREATMENT OF HEPATITIS - The present invention relates to antiviral therapies and compositions for treating or preventing Hepatitis C infections in patients and relates to other methods disclosed herein. The invention also relates to kits and pharmaceutical packs comprising compositions and dosage forms. | 2013-04-25 |
20130101555 | Proproteins and Methods of Use Thereof - The present disclosure provides for proprotein and activatable proprotein compositions. A proprotein contains a functional protein (i.e. a full length protein or functional fragment thereof) which is coupled to a peptide mask that inhibits the binding of the functional protein to its target or binding partner. An activatable proprotein contains a functional protein coupled to a peptide mask, and further coupled to an activatable linker, wherein in an non-activated state, the peptide mask inhibits binding of the functional protein to its target or binding partner and in an activated state the peptide mask does not inhibit binding of the functional protein to its target or binding partner. Proproteins can provide for reduced toxicity and adverse side effects that could otherwise result from binding of a functional protein at non-treatment sites if it were not inhibited from binding its binding partner. Proproteins can further provide improved biodistribution characteristics. Proproteins containing a peptide mask can display a longer in vivo or serum half-life than the corresponding functional protein not containing a peptide mask. The disclosure further provides methods of screening for, making, and using these proproteins. | 2013-04-25 |
20130101556 | USE OF CAFTARIC ACID AND DERIVATIVES IN FOOD SUPPLEMENT FOR REGULATING SKIN PIGMENTATION - The present invention relates generally to the field of food supplements and/or food products for cosmetic purpose. More specifically, the present invention aims to provide an ingredient containing caftaric acid and/or derivatives for preventing and/or treating hyper-pigmentation of skin, skin color imperfections such as age-spots and other skin disorders characterized by abnormal pigments. The present invention also aims at improving skin tone as well as providing a skin lightening agent. | 2013-04-25 |
20130101557 | Recombinant Adenovirus Having Anti-Angiogenesis Activity - The present disclosure relates to a recombinant adenovirus with improved angiogenesis inhibition activity and a pharmaceutical composition for inhibiting angiogenesis. The recombinant adenovirus includes: (a) an inverted terminal repeat (ITR) nucleotide sequence of an adenovirus; and (b) a nucleotide sequence coding for a chimeric decoy receptor containing (i) an extracellular domain of vascular endothelial growth factor receptor 1 (VEGFR-1) and (ii) an extracellular domain of vascular endothelial growth factor receptor 2 (VEGFR-2). The recombinant adenovirus according the present disclosure which expresses the chimeric decoy receptor inhibits angiogenesis very effectively and can be used for gene therapy for various angiogenesis-related diseases. Particularly, the recombinant adenovirus of the present disclosure has superior oncolytic activity. | 2013-04-25 |
20130101558 | AAV-BASED TREATMENT OF CHOLESTEROL-RELATED DISORDERS - The invention in some aspects relates to methods and compositions for assessing the effectiveness of miRNA inhibitors. In other aspects of the invention, methods and compositions for treating cholesterol related disorders are provided. In one aspect of the invention, miRNA inhibitors against miR-122 and rAAV-based compositions comprising the same are provided. | 2013-04-25 |
20130101559 | ANTI-MICROBIAL AGENT FROM PAENIBACILLUS SP. AND METHODS AND USES THEREOF - The present invention provides, in part, a | 2013-04-25 |